Amniotic Membrane Market Report 2026

Amniotic Membrane Market Overview

• Amniotic Membrane market size has reached to $1.88 billion in 2025 • Expected to grow to $3.15 billion in 2030 at a compound annual growth rate (CAGR) of 10.9% • Growth Driver: The Rising Transplant Activity Is Driving The Market Due To Expanding Surgical Needs And Increased Graft Utilization • Market Trend: Innovations In Amniotic Membrane Technology Enhance Treatment Options For Ocular Surface Disorders • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Amniotic Membrane Market?

The amniotic membrane is the placenta's deepest layer, consisting of an avascular stromal matrix and a thick foundation membrane. It has several applications in regenerative medicine. It is used as a dressing in different surgical subspecialties to promote wound healing and reduce inflammation. The main products of the amniotic membrane are the cryopreserved amniotic membrane and lyophilization amniotic membrane. Lyophilization amniotic membrane refers to the process of preserving something by freezing it very quickly and then subjecting it to a vacuum which removes ice. The various applications involved surgical wounds, ophthalmology, and others, which are used in hospitals, ambulatory surgical centers (ASCs), specialty clinics, and research and academic institutes.

What Is The Amniotic Membrane Market Growth Forecast?

The amniotic membrane market size is expected to see rapid growth in the next few years. It will grow to $3.15 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to increasing demand for advanced wound healing solutions, rising use in minimally invasive surgeries, expansion of outpatient surgical procedures, growing focus on biologic-based therapies, increasing regulatory clarity for tissue-based products. Major trends in the forecast period include increasing use of amniotic membranes in regenerative therapies, rising adoption in ophthalmic procedures, expansion of wound care applications, growing demand for cryopreserved products, enhanced focus on biologic safety standards.

Global Amniotic Membrane Market Segmentation

1) By Product: Cryopreserved Amniotic Membrane, Lyophilization Amniotic Membrane 2) By Application: Surgical Wounds, Ophthalmology, Other Applications 3) By End-Use: Hospitals, Ambulatory Surgical Centers (ASCs), Other End-Users Subsegments: 1) By Cryopreserved Amniotic Membrane: Dehydrated Cryopreserved Amniotic Membrane, Fresh Cryopreserved Amniotic Membrane 2) By Lyophilization Amniotic Membrane: Sterilized Lyophilized Amniotic Membrane, Non-Sterilized Lyophilized Amniotic Membrane

What Are The Drivers Of The Amniotic Membrane Market?

The rising transplant activity is expected to propel the growth of the amniotic membrane market going forward. Transplantation involves the surgical transfer of tissues or organs from a donor to a recipient and often utilizes amniotic membranes in surgical and reconstructive procedures to enhance tissue repair and recovery. The increase in transplant activity is driven by factors such as improved organ donation awareness, advances in surgical techniques, and enhanced donor-recipient matching processes. Amniotic membrane allografts support post-transplant healing by providing a biologically active extracellular matrix and regulatory proteins that promote tissue regeneration. For instance, in January 2024, according to the Organ Procurement and Transplantation Network (OPTN), a US-based organization that manages the national organ transplant system, driven by consecutive annual increases, the United States recorded 46,632 total organ transplants in 2023 up 8.7 percent from 2022 and 41,119 deceased-donor transplants in 2024, reflecting a further 3.6 percent rise over 2023. Therefore, the rising transplant activity is driving the growth of the amniotic membrane industry. The increasing prevalence of chronic diseases is expected to propel the growth of amniotic membrane market going forward. Chronic disease refers to a form of illness that lasts for three months or more and can deteriorate with time. Amniotic membrane’s unique properties, such as anti-inflammatory and regenerative capabilities, make it valuable in managing chronic conditions, reducing complications, and addressing tissue damage. Amniotic membrane's versatility extends its use across various medical specialties, meeting the demand for effective therapeutic solutions associated with chronic diseases. For instance, in February 2024, according to the World Health Organization, a Switzerland-based agency of the United Nations, It is projected that over 35 million new cancer cases will arise by 2050, marking a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the increasing prevalence of chronic diseases is driving the growth of the amniotic membrane industry.

Key Players In The Global Amniotic Membrane Market

Major companies operating in the amniotic membrane market are MiMedx Group Inc, Organogenesis Holdings Inc, Amnio Technology LLC, Applied Biologics LLC, Human Regenerative Technologies LLC, Skye Biologics Inc, Amniox Medical Inc, Bio-Tissue Inc, TissueTech Inc, Osiris Therapeutics Inc, VIVEX Biologics Inc, Merakris Therapeutics Inc, Celularity Inc, BioLab Sciences, LifeCell International Pvt. Ltd., FzioMed Inc, Corza Ophthalmology, Integra LifeSciences Co, Smith & Nephew, RTI Surgical

Global Amniotic Membrane Market Trends and Insights

Major companies operating in the amniotic membrane market are focusing on developing advanced allografts to improve patient care and clinical outcomes. Amniotic membrane allografts refer to tissue derived from the innermost layer of the placenta, used to treat ocular and surgical wounds by providing a natural extracellular matrix and growth factors to promote healing. For instance, in December 2024, BioTissue, a US-based biotechnology company, launched CAM360 AmnioGraft (CAM360 AG), a ringless, shelf-stable cryopreserved amniotic membrane for treating mild to moderate dry eye and early-stage neurotrophic keratitis. The product offers eye care professionals versatile application options, including use under a bandage contact lens or with a collagen shield, and supports rapid symptom relief within 48 hours. CAM360 AG expands treatment choices while simplifying inventory management for clinics. Therefore, innovations like CAM360 AG are driving growth in the amniotic membrane market.

Regional Outlook

North America was the largest region in the amniotic membrane market share in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Amniotic Membrane Market?

The amniotic membrane market consists of sales of epithelium, basement membrane, and stroma. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Amniotic Membrane Market Report 2026?

The amniotic membrane market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the amniotic membrane industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.